These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 26528929)
21. Crystal structure of a designed tetratricopeptide repeat module in complex with its peptide ligand. Cortajarena AL; Wang J; Regan L FEBS J; 2010 Feb; 277(4):1058-66. PubMed ID: 20089039 [TBL] [Abstract][Full Text] [Related]
22. Analysis of Hsp90 cochaperone interactions reveals a novel mechanism for TPR protein recognition. Chadli A; Bruinsma ES; Stensgard B; Toft D Biochemistry; 2008 Mar; 47(9):2850-7. PubMed ID: 18211007 [TBL] [Abstract][Full Text] [Related]
24. An unstructured C-terminal region of the Hsp90 co-chaperone p23 is important for its chaperone function. Weikl T; Abelmann K; Buchner J J Mol Biol; 1999 Oct; 293(3):685-91. PubMed ID: 10543959 [TBL] [Abstract][Full Text] [Related]
25. Tricyclic series of heat shock protein 90 (Hsp90) inhibitors part I: discovery of tricyclic imidazo[4,5-c]pyridines as potent inhibitors of the Hsp90 molecular chaperone. Vallée F; Carrez C; Pilorge F; Dupuy A; Parent A; Bertin L; Thompson F; Ferrari P; Fassy F; Lamberton A; Thomas A; Arrebola R; Guerif S; Rohaut A; Certal V; Ruxer JM; Gouyon T; Delorme C; Jouanen A; Dumas J; Grépin C; Combeau C; Goulaouic H; Dereu N; Mikol V; Mailliet P; Minoux H J Med Chem; 2011 Oct; 54(20):7206-19. PubMed ID: 21972823 [TBL] [Abstract][Full Text] [Related]
26. C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances. Muller P; Ruckova E; Halada P; Coates PJ; Hrstka R; Lane DP; Vojtesek B Oncogene; 2013 Jun; 32(25):3101-10. PubMed ID: 22824801 [TBL] [Abstract][Full Text] [Related]
27. Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors. Casale E; Amboldi N; Brasca MG; Caronni D; Colombo N; Dalvit C; Felder ER; Fogliatto G; Galvani A; Isacchi A; Polucci P; Riceputi L; Sola F; Visco C; Zuccotto F; Casuscelli F Bioorg Med Chem; 2014 Aug; 22(15):4135-50. PubMed ID: 24980703 [TBL] [Abstract][Full Text] [Related]
28. N-terminal and C-terminal modulation of Hsp90 produce dissimilar phenotypes. Wang Y; McAlpine SR Chem Commun (Camb); 2015 Jan; 51(8):1410-3. PubMed ID: 25333923 [TBL] [Abstract][Full Text] [Related]
29. High-throughput assay for the identification of Hsp90 inhibitors based on Hsp90-dependent refolding of firefly luciferase. Galam L; Hadden MK; Ma Z; Ye QZ; Yun BG; Blagg BS; Matts RL Bioorg Med Chem; 2007 Mar; 15(5):1939-46. PubMed ID: 17223347 [TBL] [Abstract][Full Text] [Related]
30. Functional dissection of cdc37: characterization of domain structure and amino acid residues critical for protein kinase binding. Shao J; Irwin A; Hartson SD; Matts RL Biochemistry; 2003 Nov; 42(43):12577-88. PubMed ID: 14580204 [TBL] [Abstract][Full Text] [Related]
31. [Thermosensitization of tumor cells with inhibitors of chaperone activity and expression]. Kudriavtsev VA; Makarova IuM; Kabakav AE Biomed Khim; 2012; 58(6):662-72. PubMed ID: 23350198 [TBL] [Abstract][Full Text] [Related]
32. Development and optimization of a useful assay for determining Hsp90's inherent ATPase activity. Avila C; Kornilayev BA; Blagg BS Bioorg Med Chem; 2006 Feb; 14(4):1134-42. PubMed ID: 16213144 [TBL] [Abstract][Full Text] [Related]
33. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Connell P; Ballinger CA; Jiang J; Wu Y; Thompson LJ; Höhfeld J; Patterson C Nat Cell Biol; 2001 Jan; 3(1):93-6. PubMed ID: 11146632 [TBL] [Abstract][Full Text] [Related]
34. Design strategies to target crystallographic waters applied to the Hsp90 molecular chaperone. Kung PP; Sinnema PJ; Richardson P; Hickey MJ; Gajiwala KS; Wang F; Huang B; McClellan G; Wang J; Maegley K; Bergqvist S; Mehta PP; Kania R Bioorg Med Chem Lett; 2011 Jun; 21(12):3557-62. PubMed ID: 21612924 [TBL] [Abstract][Full Text] [Related]
35. MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90. Ren J; Bharti A; Raina D; Chen W; Ahmad R; Kufe D Oncogene; 2006 Jan; 25(1):20-31. PubMed ID: 16158055 [TBL] [Abstract][Full Text] [Related]
36. Effect of geldanamycin on the kinetics of chaperone-mediated renaturation of firefly luciferase in rabbit reticulocyte lysate. Thulasiraman V; Matts RL Biochemistry; 1996 Oct; 35(41):13443-50. PubMed ID: 8873613 [TBL] [Abstract][Full Text] [Related]
37. Combined in silico and experimental approach for drug design: the binding mode of peptidic and non-peptidic inhibitors to hsp90 N-terminal domain. Tomaselli S; Meli M; Plescia J; Zetta L; Altieri DC; Colombo G; Ragona L Chem Biol Drug Des; 2010 Nov; 76(5):382-91. PubMed ID: 20925690 [TBL] [Abstract][Full Text] [Related]
38. Synthesis and Structure-Activity Relationships of Inhibitors That Target the C-Terminal MEEVD on Heat Shock Protein 90. Rahimi MN; Buckton LK; Zaiter SS; Kho J; Chan V; Guo A; Konesan J; Kwon S; Lam LKO; Lawler MF; Leong M; Moldovan GD; Neale DA; Thornton G; McAlpine SR ACS Med Chem Lett; 2018 Feb; 9(2):73-77. PubMed ID: 30555625 [TBL] [Abstract][Full Text] [Related]
39. Experimental and structural testing module to analyze paralogue-specificity and affinity in the Hsp90 inhibitors series. Taldone T; Patel PD; Patel M; Patel HJ; Evans CE; Rodina A; Ochiana S; Shah SK; Uddin M; Gewirth D; Chiosis G J Med Chem; 2013 Sep; 56(17):6803-18. PubMed ID: 23965125 [TBL] [Abstract][Full Text] [Related]
40. Specific Binding of Tetratricopeptide Repeat Proteins to Heat Shock Protein 70 (Hsp70) and Heat Shock Protein 90 (Hsp90) Is Regulated by Affinity and Phosphorylation. Assimon VA; Southworth DR; Gestwicki JE Biochemistry; 2015 Dec; 54(48):7120-31. PubMed ID: 26565746 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]